CBD Archives - Page 7 of 13 - InvestorWire (IW)

Monday Dec 27, 2021 - 1:02 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expects Study Results to Show its Patented Tech’s Value in Treating Hypertension Patients

Lexaria Bioscience is preparing to file an Investigational New Drug application with the U.S. Food and Drug Administration for its patented technology’s use in treating hypertension (high blood pressure)The company has completed multiple studies of the benefits of DehydraTECH(TM), in combination with cannabidiol to combat hypertension conditions and consequentially benefit cardiovascular patientsLexaria recently announced that it is nearing completion of a third human study in…

Monday Dec 27, 2021 - 11:41 am

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Announces White-Label Manufacturing Agreement With Averi Health Products

BevCanna Enterprises is a diversified health & wellness beverage company which specializes in providing white-label production and distribution solutions to its various partnersThe company recently entered into a manufacturing and distribution agreement with Averi Health Products, which will see BevCanna market Averi’s diverse range of non-alcoholic, cannabis-infused cocktailsBevCanna has recently announced tie-ups with Keef Brands as well as with The Tinley Beverage Company to produce…

Wednesday Dec 22, 2021 - 11:56 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Major Discovery; Increasing the Effectiveness of Orally Administered CBD

In a recent human clinical trial, HYPER-H21-2, DehydraTECH™-CBD reduced arterial stiffness, potentially broadening Lexaria's application's ability to treat cardiovascular and other diseases beyond hypertensionLexaria’s patented technology DehydraTECH improves how APIs enter the bloodstream –making multiple benefits possible such as increased delivery speed, increase in brain absorbency, higher bioavailability, and lower costsThe company has patent protection received for delivery of nicotine, vitamins, NSAIDs, terpenes and cannabinoids;…

Tuesday Dec 21, 2021 - 11:42 am

As Cannabis Market Continues to Expand, Marijuana Company of America Inc. (MCOA) Anticipates Sustained Growth Following Record-Breaking Quarter

Education and job opportunities are being created for the sector, as more states and more countries around the word are pushing for cannabis legalizationMCOA offers diverse operations that include both wholly-owned subsidiaries and investment interests, including Cannabis Global Inc., Eco Innovation Group Inc., and Natural Plant ExtractDuring Q3 2021, the company saw its highest revenue earning quarter since it became public Despite challenges posed by…

Tuesday Dec 21, 2021 - 10:10 am

BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) TRACE Natural Alkaline Spring Water Named as the Official Water Supplier for Vancouver’s 2022 Canadian E-Prix Event

BevCanna Enterprises’ TRACE line of natural alkaline and mineral-infused spring waters have been named as the official water supplier for Vancouver’s 2022 Canadian E-Prix eventTRACE Natural Alkaline Spring Water, which originates from BevCanna’s wholly owned natural spring water aquifer in British Columbia, are renowned for their optimal mineral content and eco-friendly packaging BevCanna will launch a unique, commemorative package for its signature water brand in the…

Monday Dec 20, 2021 - 12:11 pm

RYAH Group Inc. (CSE: RYAH) Releases Medical Cannabis Report on Cancer and Adverse Cancer Treatment Effects

RYAH recently released report highlighting medical cannabis treatment for cancer and adverse effects of cancer treatmentData from 80,000 sessions logged between January 1, 2018 and November 15, 2021 tracked conditions including anxiety, cachexia, fatigue, pain, nausea, and stress62% of patients reported a moderate experience using cannabis to treat cancer-related conditionsRYAH supports cancer research and treatment with IoT product ecosystem comprised of volume-control devices, medicine-carrying components,…

Friday Dec 17, 2021 - 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-CBD Reduces Arterial Stiffness in Study HYPER-H21-2 Broadening Applications Beyond Hypertension

Cardiovascular diseases are the leading cause of death worldwide and arterial stiffness serves as a significant marker of related conditions, including hypertension (high blood pressure)The company’s studies earlier this year indicated the potential of DehydraTECH to improve CBD’s ability to reduce high blood pressure in a rapid and sustainable manner that exceeds the ability of a generic CBD formulationArterial stiffness is a noted indicator of…

Thursday Dec 16, 2021 - 11:51 am

Marijuana Company of America Inc. (MCOA) Achieving Growth Through Acquisitions and Strategic Partnerships

MCOA just posted its highest quarterly revenue yet in Q3 2021, attributed to the cDistro acquisition, which was completed towards the end of Q2 2021MCOA looks forward to having another record-breaking quarter in Q4, 2021, primarily attributed to additional benefits of the cDistro acquisition, along with strategic partnerships with key players within the legal cannabis and industrial hemp sectorsThe company continues to forge these partnerships…

Thursday Dec 16, 2021 - 10:48 am

Flora Growth Corp. (NASDAQ: FLGC) Subsidiary Introduces New Dry Herb Consumer Products; Issues 2022 Revenue Guidance of $35-45 Million

Flora Growth’s subsidiary, Vessel Brand, recently introduced new products for dry herb consumption and anticipates releasing additional products in 2022FLGC acquired Vessel in a transaction that closed in NovemberFounded in 2018, Vessel is an industry leader in the cannabis consumer technology and accessories spaceFlora Growth also announced a 2022 revenue guidance of $35-45 millionCEO Luis Merchan held a webinar on December 14 in which he…

Tuesday Dec 14, 2021 - 12:54 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Participates in the Benzinga Global Small Cap Conference; Committed to Innovation and Improving Quality of Life

Lexaria presented at this year’s Benzinga Global Small Cap Conference held on December 8-9, 2021The event came right after the company announced human clinical hypertension study HYPER-H21-4, its most ambitious one yetLexaria plans to sublicense its patented DehydraTECH(TM) technology worldwide, allowing for more people to benefit from itGoing into 2022, the company looks forward to reporting on results from its HYPER-H21-3 clinical study and receiving…

Friday Dec 10, 2021 - 10:21 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Upcoming R&D Programs Targeting Global Markets Totaling Over $160 Billion

Lexaria Bioscience plans to launch approximately 12 applied research and development programs in 2022The programs are designed to explore the ability of the company’s patented DehydraTECH(TM) to improve drug delivery processes for multiple indicationsResearch will continue into the use of DehydraTECH-CBD for high blood pressure, as well as the technology’s potential for oral nicotine delivery Diabetes, rheumatoid disease, Alzheimer’s Disease, and estrogen delivery, are some…

Thursday Dec 09, 2021 - 1:55 pm

Flora Growth Corp. (NASDAQ: FLGC) Launches European and Mexican Exports of CBD Skincare Brands

Colombian cannabis cultivator and international wellness product builder Flora Growth Corp. is building a global pipeline for its wide array of branded CBD and medicinal cannabis productsThe company recently announced that it has begun fulfilling the first orders for its Mind Naturals and Awe CBD skincare brands with exports to Spain and Mexico outlets this monthFlora Growth cultivates cannabis at its 100-hectare (247-acre) property in…

Wednesday Dec 08, 2021 - 12:28 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Improving Bioavailability of Pharmaceuticals and Therapeutics

Around 40% of available marketed drugs are poorly bioavailable or soluble, and about 90% of New Chemical Entities are known for their low solubility and permeabilityLexaria’s patented DehydraTECH(TM) technology offers a solution by improving how APIs (active pharmaceutical ingredients) enter the bloodstreamDehydraTECH achieves this by bypassing first-pass-liver metabolismBy doing so, Lexaria is facilitating faster and much more thorough drug delivery In a report published in…

Tuesday Dec 07, 2021 - 9:00 am

RYAH Group Inc. (CSE: RYAH) to Deliver Solutions for Clinicians Examining Cannabis Efficacy in Cancer Treatment

Multiple ongoing studies are researching the relationship between medical cannabis and cancer treatmentThe viability of clinical studies within the sector is hampered by lack of exact measurement of a patient’s intakeRYAH Group intends to resolve this issue with the launch of it’s proprietary RYAH Smart Dry Herb InhalerThe company successfully delivered on its first Inhaler order in May 2021, and announced that they had received…

Friday Dec 03, 2021 - 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Enters Cannabis Beverages Market, Extends Portfolio of Luxury Products with Tonino Lamborghini Licensing Agreement

Flora Growth recently entered into a licensing agreement to produce and distribute Tonino Lamborghini-branded cannabis beverages across North America and Colombia, with an initial focus on the U.S. marketThe company will produce the product line using molecular tagging and authentication technology that will guarantee product verification and allay concerns of counterfeit productsThrough the licensing agreement, Flora has entered into the cannabis beverages market amid increasing…

Thursday Dec 02, 2021 - 9:00 am

Marijuana Company of America Inc. (MCOA) Leverages Strategic Partnerships to Facilitate Growth Within the Industry

The global cannabis market was valued at $22.10 billion and is expected to grow at a CAGR of 13.9% by 2026. The growing trend was reflected by Green Wednesday salesMCOA has expanded its interests into Latin America and has strategic partnerships in place, as well as wholly-owned subsidiaries in its portfolioLeadership team has set high standards for the company and plans to leverage the strategic…

Wednesday Dec 01, 2021 - 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Expands its Line of Lifestyle Brands Following Vessel’s Merger into a Wholly-Owned Subsidiary

Flora Growth has followed through with its definitive agreement to acquire 100% of Vessel’s equity interestsThis acquisition opens Flora up to the North American market, in addition to expanding its brand portfolio, with a proven operator that has achieved trailing 12-months revenue of $6.6 million and year-over-year growth of 90%It also serves to strengthen Flora’s management with the addition of Vessel’s leadership onto the teamThis…

Tuesday Nov 30, 2021 - 9:30 am

Marijuana Company of America Inc. (MCOA) Reports Highest Quarterly Revenue Yet in Q3 2021 on the Back of New Acquisition, Expects Another Record-Breaking Quarter in Q4 2021

MCOA’s Q3 2021 revenue increased 731% year on year from $53,195 in Q3 2020 to $442,178 in Q3 2021The company attributed this growth to its recent acquisition of cDistro, one of the fastest-growing distributors in North AmericacDistro’s acquisition is part of a strategic shift as the company looks to expand into new areas within the cannabis industryMCOA expects another record-breaking quarter in Q4 2021 as…

Monday Nov 29, 2021 - 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q1 2022 Financial Results, Business Update Showing Positive Momentum Across All Its Programs

InMed Pharmaceuticals released Q1 2022 financial results in which it reported a year-on-year increase in research and development expenses primarily due to increased activities related to INM-755 clinical trialsThe company’s cash, cash equivalents, and short-term investments also grew quarter over quarter from $7.4 million to $15.4 millionFollowing the closing of BayMedica’s acquisition, the integrated teams are working together with a focus on launching selected rare…

Wednesday Nov 24, 2021 - 8:00 am

Marijuana Company of America Inc. (MCOA) Set to Launch VapeTV U.S. in a Three-Way Partnership

MCOA just signed an LOI with VapeTV UK and Jasleen Enterprises for the launch of VapeTV U.S.This new company is set to offer in-store advertising within retail vape storesIt will capitalize on the growing CBD industry and the ever-increasing demand for in-store media advertising in the United States Marijuana Company of America (OTC: MCOA) has announced the signing of a non-binding letter of intent (“LOI”)…

Wednesday Nov 24, 2021 - 8:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) DehydraTECH(TM) Drug Delivery Technology Finding Multiple Medical Applications

Lexaria intends to undertake its most ambitious study yet – HYPER-H21-4 – as it pursues regulatory approval for DehydraTECH-CBD for potential use as a treatment for hypertensionHYPER-H21-4 will build on successes witnessed in initial human hypertension studiesThe company, which has a fully funded R&D budget, recently announced new R&D programs covering multiple conditions, including dementia, diabetes, and rheumatoid diseaseLexaria is committed to improving lives and…

Tuesday Nov 23, 2021 - 8:30 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Adding to its Growing Retail Presence with Rapid Developments in Florida

Red White & Bloom Brands is building a multi-state operation in the cannabis and hemp industries through state subsidiaries focused on markets in Florida, Michigan, Illinois, Arizona and CaliforniaThe company is now rapidly building up its cultivation and retail operations in Florida, advancing from regulatory approval in the state last month to the startup of growing activity to supply existing and soon-to-open dispensaries in four…

Thursday Nov 18, 2021 - 8:00 am

Hero Technologies Inc. (HENC) Subsidiary Looks to Leverage Position in $2B Massachusetts Marijuana Market

HENC subsidiary evaluating, pursuing property acquisitions; beginning process to obtain cultivation, sales licensesSales have doubled in the past year, according to state’s seed-to-sale tracking systemHENC working with top cannabis law firm to spearhead the process With Massachusetts reporting marijuana sales reaching $2 billion since the state approved the adult-use market (https://ibn.fm/S8IvV), savvy cannabis companies operating in the state are looking to leverage opportunity for growth.…

Thursday Nov 18, 2021 - 8:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces 2022 DehydraTECH(TM) R&D Programs, Including Investigations into Alzheimer’s Disease and Diabetes

Lexaria’s 2022 R&D programs are set to include research on hormone replacement, dementia, rheumatoid disease, and diabetes, among other conditionsThe program builds on findings from 2021 studies which supported significant advances in the oral nicotine, heart disease, and antiviral marketsThe 2022 program will continue to focus on the company’s patented DehydraTECH drug delivery platformLexaria will also be conducting pharmacokinetic and efficacy modeling studies in animals…

Wednesday Nov 17, 2021 - 8:00 am

Marijuana Company of America Inc. (MCOA) Is ‘One to Watch’

The VBF acquisition is expected to be accretive to MCOA’s revenue and EBITDA forecasts for 2022The company launched new subsidiaries in Brazil and Uruguay to distribute its hempsmart premium product line in Latin AmericaThe company recently launched a new social media marketing campaign via Instagram, Twitter, TikTok, etc.The global legal marijuana market was valued at $9.1 billion in 2020 and is forecast to grow at…

Tuesday Nov 16, 2021 - 8:30 am

CannabisNewsWire Recaps Success of ‘USA CBD Expo’ as Team Rebrands Event Series to ‘Alternative Products Expo’

Date: OCTOBER 28-30, 2022 Venue: Chicago With the recent completion of their jumbo event in Chicago, the USA CBD Expo team has rebranded their event series as ‘Alternative Products Expo’. Chicago’s USA CBD Expo, the country's biggest CBD event and covering the largest assortment of hemp and CBD goods, imparted critical knowledge to niche company owners on how to reach new consumers and expand their…

Monday Nov 15, 2021 - 8:30 am

Hero Technologies Inc. (HENC) Committed to Safety as Michigan Legislators Look to Restrict Caregiver Cultivation in Growing Market

Michigan lawmakers approve bills designed to restrict medical marijuana cultivation by caregivers Marijuana sales in the state are increasing.Top priority is concern about the safety of untested medical marijuana grown by caregivers. With Michigan seeing record sales this year, the state is looking to provide regulation over the growing market in efforts to ensure quality and safety. Recently, Michigan lawmakers approved bills designed to restrict medical…

Friday Nov 12, 2021 - 1:22 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Embarks on its Most Ambitious Hypertension Clinical Study Yet: HYPER-H21-4

Lexaria has embarked on its HYPER-H21-4 study, its fourth hypertension clinical study, and it's most ambitious yetThis study builds on the HYPER-H21-1 and HYPER-H21-2 findings, as well as the HYPER-H21-3 study that is set to begin dosing in mid-November 2021Lexaria’s goal is to pursue regulatory approval for its proprietary DehydraTECH-CBD for potential use as a treatment for high blood pressureStudy protocols are being readied for…

Friday Nov 12, 2021 - 8:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Commences Installation of 30 Growing Pods, Produces First Batch of Chocolates at New Sanderson Production Facility

Red White & Bloom has officially entered Phase 2 of an aggressive three-phase expansion plan in FloridaPhase 2 involves the installation and commissioning of 30 customized, self-contained growing podsRWB recently received OMMU approval for the first five pods that it subsequently installed and commissionedThe company, through its Red White & Bloom Florida LLC subsidiary, produced the first batch of chocolates from the new Sanderson production…

Wednesday Nov 10, 2021 - 11:51 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Files International Patent Application for Treating Neurodegenerative Diseases Using a New Rare Cannabinoid

InMed Pharmaceuticals has filed an international patent application that specifies a rare cannabinoid that may inhibit or slow the progression of neurodegenerative disease and potentially enhance the neuronal functionWith neurogenerative diseases affecting millions worldwide and the cost of treating patients expected to rise in the future, finding treatments and cures is a matter of increasing urgencyInMed’s patent application is a promising start, expanding the company’s…

Friday Nov 05, 2021 - 10:41 am

German Cannabis Market Expected to Liberalize Post Election, RYAH Group Inc. (CSE: RYAH) Enters Germany Via Observational Study

German Social Democrat-led coalition expected to liberalize medical cannabis market Analysts predict over one million medical cannabis patients in Germany by 2024, market estimated to reach $8.9 billion by 2028RYAH entered German market via observational study with Four 20 Pharma GmbHRYAH provides IoT product ecosystem of volume-control devices, medicine-carrying components, mobile applicationsRYAH ecosystem offers reliable way for researchers and clinicians to develop well-controlled research environments Germany’s…

Wednesday Nov 03, 2021 - 12:29 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Commences New Animal Study Evaluating Patented DehydraTECH(TM) Technology’s Efficacy in Reducing/Inhibiting Seizure Activity; Strengthens IP Portfolio

Lexaria recently announced the commencement of EPIL-A21-1, an animal study to evaluate whether DehydraTECH-CBD has similar or superior efficacy in reducing or inhibiting seizure activity compared to FDA-approved seizure drug, EpidiolexThe study will also compare DehydraTECH-CBD to generic CBDEPIL-A21-1 has entered early-stage preparatory work, with results expected in Q3 2022Lexaria received new patent awards in Mexico and Japan, strengthening its IP portfolio to 23 granted…

Monday Nov 01, 2021 - 1:18 pm

Successful Ginkgo Bioworks SPAC IPO Highlights Available Industry Opportunities for InMed Pharmaceuticals Inc. (NASDAQ: INM) and Synthetic Cannabinoid Production

Special purpose acquisition company Soaring Eagle Acquisition Corp. combined with Ginkgo Bioworks to form publicly listed Ginkgo Bioworks Holdings Inc., in what is the largest-ever biotechnology go-public transactionGinkgo Bioworks is known for its work in the commercial-scale production of a rare cannabinoid, CBG, for use in a multitude of industrial needsInMed uses multiple manufacturing approaches to synthetically produce rare cannabinoids, including CBC which is currently…

Friday Oct 29, 2021 - 11:58 am

Flora Growth (FLGC) Receives Global Medical Cannabis Certification, Launches New CBD Brand

Flora Growth Corp. is an international cannabis consumer packaged goods distributor and cultivator based in Colombia that has built an ecosystem that will support market-leading innovation within categories that matter most to consumers exploring plant-based consumer goods.The company recently obtained the Good Agricultural and Collection Practices (“GACP”) certification from international certification agency and global leader in medical cannabis certification Control Union Medical Cannabis Standard (“CUMCS”)Flora…

Friday Oct 29, 2021 - 11:26 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Makes Strategic Additions to its Leadership; Completes Platinum Vape Management Transition

RWB appointed Chris Ecken as the new CFO effective October 2021Ecken will lend over 25 years of experience from the alcohol beverage industry, helping RWB to shape sustainable long-term growthRWB also announced Colby De Zen’s appointment to its board of directorsHe will be integral to RWB’s move to close critical assets in Michigan and expedite expansions in Florida, California, Arizona, Illinois, Massachusetts and OklahomaRWB also…

Tuesday Oct 26, 2021 - 6:16 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Addresses the Needs of Medical THC Users

Lexaria’s THC absorption animal study yielded promising results on the patented DehydraTECH(TM) technologyIt showed that the technology required a shorter time to deliver the same THC levels than concentration-matched controlsLexaria believes that through DehydraTECH, it is meeting the needs of medical THC users with its rapid delivery, increased overall THC delivery and high brain tissue delivery Lexaria Bioscience's (NASDAQ: LEXX) just-concluded oral tetrahydrocannabinol (“THC”) absorption…

Monday Oct 25, 2021 - 11:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Subsidiary Completes Development of Licensed Apopka Facility, Commences Cultivation Targeting Q4 Harvest

Red White & Bloom completed the build-out of its Apopka facility – phase one of a development strategy – and immediately commenced cultivation following the receipt of a cultivation licenseThe initial licensed area is projected to generate annual revenue in excess of $10 millionThe Apopka facility will support phase two of the strategy, which entails the activation of thirty customized, self-contained growing podsPhase three will…

Friday Oct 22, 2021 - 9:00 am

New Study Underscores Rapidity of Oral Drug Bio-delivery Using Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology as an Alternative to Smoking and Vaping

Oral drug delivery innovator Lexaria Bioscience is focused on providing alternatives to smoked or inhaled tobacco and cannabis products to help consumers reduce the threat to their lungsLexaria’s patented technology — DehydraTECH(TM) — is a solution that processes active pharmaceutical ingredients into a powder or liquid form that can then be ingested with less harm than inhalation, while providing rapidity similar to inhalation substancesDehydraTECH has…

Thursday Oct 21, 2021 - 12:47 pm

Flora Growth Corp.’s (NASDAQ: FLGC) Leadership and Advisory Team Steering Company to Greater Heights

The growing cannabis industry is experiencing a rise in demand for experienced business executives to guide companies toward the topFlora Growth, which has achieved numerous milestones, is a testament to the importance of experienced leadershipEstablished in 2019, Flora was the first all-outdoor cannabis cultivation company to list on NASDAQ and has the largest licensed cultivation footprint in ColombiaThe company also boasts the lowest production cost…

Wednesday Oct 20, 2021 - 9:28 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Inches Closer to Revolutionizing the Nicotine Industry with its Alternative Nicotine Delivery

Lexaria’s recent animal study on its patented DehydraTECH(TM) technology on nicotine absorption yielded ground-breaking resultsThis study builds on an earlier 2018 study that demonstrated effective delivery of nicotine to the central nervous system in a rodent studyThe study’s success will serve as the foundation for a human trial that will compare the DehydraTECH-nicotine pouch performance to leading brands Zacks Small Cap Research recently did a…

Articles

Articles Category: CBD

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions